Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gosalvez

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1982
On the irreproducibility of thioprolineM Gosalvez
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1986
Both points of viewM Gosalvez
Advances in Experimental Medicine and Biology|January 1, 1976
Control mechanisms of oxygen and glucose utilization in tumoursM Gosalvez, S Weinhouse
Cancer Research|November 1, 1973
Letter: Induction of rat mammary adenomas with respiratory inhibitory rotenoneM Gosalvez, J Merchan
Lancet (London, England)|January 12, 1980
Treatment of cancer by an inducer of reverse transformationA Brugarolas, M Gosalvez
European Journal of Cancer|July 1, 1973
Inhibition of the growth of ehrlich ascites tumors by treatment with the respiratory inhibitor rotenoneM J Figueras, M Gosalvez
European Journal of Biochemistry|July 1, 1974
Competition for ADP between pyruvate kinase and mitochondrial oxidative phosphorylation as a control mechanism in glycolysisM Gosalvez, J Pérez-García, S Weinhouse
European Journal of Cancer|August 1, 1972
Inhibition of NADH-linked respiration with the anti-cancer agent 4'-demethyl-epipodophyllotoxin thenylidene glucoside (VM-26)M Gosalvez, J Perez-Garcia, M Lopez
European Journal of Cancer|October 1, 1975
Delayed pyridine nucleotide reoxidation induced by the anticancer agent VM-26 as measured in vivo and in situ by NADH microfluorimetryM Gosalvez, R García-Cañero, H Reinhold
Cancer Research|May 1, 1981
Quantitative determination of the degree of differentiation of mammary tumors by pyruvate kinase kinetic analysisL Lopez-Alarcon, P Ruiz, M Gosalvez
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1982
On the irreproducibility of thioprolineM Gosalvez
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1986
Both points of viewM Gosalvez
Advances in Experimental Medicine and Biology|January 1, 1976
Control mechanisms of oxygen and glucose utilization in tumoursM Gosalvez, S Weinhouse
Cancer Research|November 1, 1973
Letter: Induction of rat mammary adenomas with respiratory inhibitory rotenoneM Gosalvez, J Merchan
Lancet (London, England)|January 12, 1980
Treatment of cancer by an inducer of reverse transformationA Brugarolas, M Gosalvez
European Journal of Cancer|July 1, 1973
Inhibition of the growth of ehrlich ascites tumors by treatment with the respiratory inhibitor rotenoneM J Figueras, M Gosalvez
European Journal of Biochemistry|July 1, 1974
Competition for ADP between pyruvate kinase and mitochondrial oxidative phosphorylation as a control mechanism in glycolysisM Gosalvez, J Pérez-García, S Weinhouse
European Journal of Cancer|August 1, 1972
Inhibition of NADH-linked respiration with the anti-cancer agent 4'-demethyl-epipodophyllotoxin thenylidene glucoside (VM-26)M Gosalvez, J Perez-Garcia, M Lopez
European Journal of Cancer|October 1, 1975
Delayed pyridine nucleotide reoxidation induced by the anticancer agent VM-26 as measured in vivo and in situ by NADH microfluorimetryM Gosalvez, R García-Cañero, H Reinhold
Cancer Research|May 1, 1981
Quantitative determination of the degree of differentiation of mammary tumors by pyruvate kinase kinetic analysisL Lopez-Alarcon, P Ruiz, M Gosalvez
Pageof 3